Objective: To investigate if in preterm newborns, an early adrenocorticotropin hormone (ACTH) test can identify possible transient adrenal insufficiency (TAI), using significant hypotension as a clinical marker.
Introduction
During the last trimester of pregnancy, the fetal adrenal gland undergoes significant anatomical and functional maturation for adaptation to the extra-uterine life. 1, 2 In preterm newborns developmental immaturity combined with the increased demands of critical illness may result in insufficient cortisol production to maintain homeostasis in the face of acute stress or illness, despite apparently normal cortisol levels. This condition has been labeled 'transient or relative adrenal insufficiency'. 1, [3] [4] [5] [6] [7] Transient adrenal insufficiency (TAI) in the first days of life is associated with refractory hypotension, significant respiratory distress, patent ductus arteriosus and bronchopulmonary dysplasia (BPD). 1, 5, [8] [9] [10] [11] Of critical concern is that significant hypotension is associated with intraventricular hemorrhage, periventricular leukomalacia, increased mortality and later neurodevelopmental disabilities in preterm infants. 12 In the critically ill premature infant, a variety of etiologies other than TAI can result in hypotension (e.g., hypovolemia, myocardial compromise, failure of vasoregulation, hyaline membrane disease, infection or a combination of these factors). 13 As a result, random cortisol levels used as a marker for adrenal insufficiency are not adequate, particularly as 'normal' cortisol levels in premature babies vary greatly. [14] [15] [16] Because of the lack of an obvious cutoff level of cortisol upon which clinicians can diagnose adrenal insufficiency early in preterm infants, a stimulation test, that is, adrenocorticotropin hormone (ACTH) test, may be a more accurate measure of adequacy of adrenal function. ACTH tests have been shown to have higher sensitivity for identifying adrenal insufficiency during critical illnesses. 4, 5 Nevertheless, the interpretation of an ACTH stimulation test needs to be based on age-specific norms as infants at differing levels of postnatal maturity have varied responses. 17 Importantly, currently no consensus exists on the diagnosis of hypoadrenalism in preterm infants based on ACTH test. 4, [18] [19] [20] Therefore, the objective of this study was to evaluate the sensitivity and specificity of the ACTH test for identifying TAI within the first few hours of life in a group of extremely preterm infants (<30 weeks gestational age (GA)), using significant hypotension that required the use of inotropes as a possible early and clinically important sign of hypoadrenalism.
Methods

Study population
We prospectively studied newborn infants of GA 24 to 29 weeks þ 6 days in the first 8 h of life admitted to the neonatal intensive care unit in Children's and Women's Health Center of British Columbia during October 2009 to December 2010. GA was determined based on last menstrual period. In cases of discrepancy of >2 weeks between early ultrasound dating (before 12 weeks of gestation) and last menstrual period, the GA was based on the ultrasound findings.
Significant hypotension was defined as hypotension that prompted initiation of inotropes. For the purpose of our study we concentrated on significant hypotension in the 1st day of life. The decision to initiate inotropes by the neonatal intensive care unit staff was based on a mean blood pressure value lower than an infant's GA in weeks, clinical signs and symptoms of decreased circulatory perfusion, and lack of response to a 10 ml kg À1 normal saline bolus. Histological chorioamnionitis was diagnosed as part of our hospital's routine pathological examination of placentas from premature births, including both in-and out-born preterm newborns' deliveries.
Infants were excluded if they had known congenital adrenal hyperplasia or received postnatal steroid therapy or blood transfusion before the ACTH study, but were not excluded if they had received only prenatal steroids.
Procedures
The ACTH test. The ACTH analog, cosyntropin (CORTROSYNF Amphastar pharmaceuticals, Scarborough, ON, Canada) 1.0 mcg kg À1 was administered intravenously. Serum cortisol levels were taken just before (baseline) and 40 min after cosyntropin administration. Blood samples of 0.3 ml were collected in plastic tubes containing EDTA (Fisher Scientific, Vancouver, BC, Canada Cat#BP120-1 (FW ¼ 372.24)) and 5.285 mg of Aprotinin (Sigma Aldrich, Oakville, ON, Canada, Cat#A-1153 (7 TIU mg À1 )) and centrifuged at 4 1C and the plasma was separated immediately and frozen at À80 1C. Serum cortisol levels were determined using Backman Coulter's competitive binding immunoenzymatic assay (cat#33600) in duplicate. The inter-and intra-assay coefficients of variability were 7.2% and 6.2%, respectively.
Functional echocardiogram
A functional echocardiogram was done in premature infants who remained hypotensive after a fluid bolus infusion and before the initiation of inotropes. If no hypotension was recorded, an echo was done at 8 h of age as a control measurements to the hypotensive group.
The echocardiogram was done for the purpose of the study and the clinical management team were kept blinded to its results. Using 2D echocardiogram and pulse Doppler, left ventricular output was calculated using the apical aortic and the long axis views. Echocardiography results were used to support the diagnosis of hypotension.
Primary outcome
Responses to early ACTH test (during the first 8 h of life) of infants who developed significant hypotension in the 1st day of life were compared with responses of infants who did not develop significant hypotension. The magnitude of change in cortisol levels post ACTH test was used to predict significant hypotension as a possible marker of hypoadrenalism.
Secondary outcomes
The association between the change in cortisol in response to the ACTH test and clinical factors associated with hypoadrenalism in the 1st days of life were analyzed: hypoglycemia (defined as glucose <1.8 mmol l
À1
, (32 mg dl À1 )), BPDFdefined as any need for oxygen treatment, continuous positive airway pressure or ventilation at 36 week corrected GA, and other factors including electrolytes disturbances, patent ductus arteriosus, necrotizing enterocolitis, intra-ventricular hemorrhage and positive cultures or death.
Statistical methods
Receiver operating characteristic curve (ROC curve) was used to determine different possible cutoff points of the ACTH test as a predictor for significant hypotension. The confidence interval for the proportions difference was calculated for the difference in outcome parameters. The difference between the left ventricular output results between groups was calculated using Wilcoxon's test. SPSS version 19 (IBM, Chicago, USA) was used for the statistical analyses.
Legal guardians were asked for consent before a threatened potentially eligible preterm delivery, or as soon as possible after the delivery. A written consent was mandatory. This study was approved by the Research Ethic Boards of Children's and Women's Health Center and the University of British Columbia.
Results
During this time-limited study, a total of 40 preterm newborns were studied. For the study group GA was 26.6 weeks (24 to 29) and mean birth weight 876 g (505 to 1360). Twelve infants (30%) required inotropes for treatment of hypotension. Functional echocardiogram before the initiation of inotropic support was done in 10/12 infants; these infants had low left ventricular output (mean: 92 ml k À1 min À1 , range: 66 to 120 ml k À1 min À1 ). The left ventricular output measured at 8 h in the non hypotensive newborns (24/28 infants) was significantly higher (mean 188, range 135 to 266 ml k À1 min
À1
), P-value <0.0001.
Hypoadrenalism-related hypotension O Hochwald et al
The area under the ROC curve (area under the curve) for the power of the percentage change in cortisol was 87% (see Figure 1) . The most accurate combination of sensitivity and specificity of the test were to use a response in cortisol after the ACTH administration of <12% from baseline ('low response to ACTH'). The sensitivity was 75% and the specificity was 93% for detecting the hypotensive newborns. Using only the post ACTH test cortisol level instead of the percentage change was less accurate in predicting hypotension (area under the ROC curve 74%). Using only the basal cortisol level, there was no ability to predict hypotension (area under the ROC curve 48%). Increase in post ACTH cortisol level <12% from baseline (low response) was associated with more hypotension and BPD, but not with more hypoglycemia, electrolyte disturbances, patent ductus arteriosus, necrotizing enterocolitis, intra-ventricular hemorrhage and positive cultures or death in the study patients (Table 1) . No differences were found between the group with low response to ACTH and the rest of the infants regarding gender or antenatal steroids treatment (Table 1) .
Hydrocortisone as treatment for refractory hypotesion that persisted despite the use of two different inotropes was used in two newborns in the 'low response' group, and in one from the group with post ACTH test cortisol level >12%.
Discussion TAI of prematurity is not uncommon in extremely low gestational age infants. This phenomenon usually appears in the 1st few days 9 and to the later development of BPD and with death.
1,9-11 Steroid treatment for preterm infants, mainly hydrocortisone, either as prophylaxis for hypotension, 21 BPD, 22 or as a rescue treatment for refractory hypotension, 23 has been shown to have positive effects on outcomes including the decrease in inotropes use and decrease in the incidence of BPD in specific populations, but comes with risks as well. Indeed, Watterberg et al. 22 demonstrated that infants given hydrocortisone were at increased risk for intestine perforation when used in combination with indomethacin treatment.
To the best of our knowledge, this is the first study to determine a cutoff for detecting TAI based on an early ACTH testing using percentage change from baseline cortisol levels in this high-risk population. The high specificity of this method has potential as a clinically useful tool for selecting a specific group of patients that may benefit from steroid supplementation.
The alternative approach whereby clinicians rely on randomly sampled cortisol levels as a marker for adrenocortical insufficiency in this population is problematic, as cortisol levels in premature infants vary significantly. 15, 16, 24 For example, Heckmann et al. 16 measured cortisol in medically stable preterm infants with a GA of <30 weeks during the first two weeks of life. Cortisol levels ranged from 66 to 744 nmol l À1 in this cohort. Saedi et al. 15 developed reference ranges for serum cortisol with sera from 39 healthy preterm infants <31 weeks of GA, with levels ranging from 20 to 688 nmol l À1 . Both low and high cortisol levels were associated with sickness and poor outcome in preterm infants. 9, 11, 25, 26 Furthermore, acutely ill patients with normal basal cortisol level but abnormal response to ACTH, have been described. 27 Corticotropin releasing hormone and ACTH stimulation tests for the assessment of the adrenal response have been found to be more accurate than cortisol levels alone as a marker for hypoadrenalism related states. 4, 5, 8, 10, 11, 25 Huysman et al. 4 described the results of ACTH test in 21 very low birth weight preterm infants on day 4 of life. Cortisol levels in ventilated preterm infants were comparable before, but significantly lower after, the administration of an ACTH analog. The higher the SNAP scores 28 were, the lower the cortisol response. Nykanen et al.
11 described ACTH test results on the 1st and 4th days of life in 89 preterm ventilated infants. Infants with poor outcome, defined as death before discharge or BPD, had significantly lower cortisol response to the ACTH administration on the 1st day of life, but not on day 4. Using a corticotropin releasing hormone test, Ng et al. 5 described the phenomenon of a TAI in very low birth weight preterms. 8, 10 In these studies, a corticotropin releasing hormone test showed normal ACTH response, but lower cortisol response on the 7th day of life in ventilated infants and in infants with refractory hypotension.
Ng et al.'s
5 findings support the approach of using an ACTH test for assessing TAI, as it appears that the upstream function of the hypothalamic pituitary adrenal axis is adequate in these infants. 8 Nevertheless, clinicians interpreting the results of an ACTH stimulation test must take into account the infant's age. 17 Currently there is no consensus on the diagnosis of hypoadrenalism in preterm infants based on ACTH test. 4, 18 For example, ACTH stimulation test performed in sick preterm infants 24 to 28 weeks GA in days 2 to 4 of life produced post ACTH cortisol levels, which covered almost a 10-fold range (165 to 1434 nmol l À1 . 19, 20 ) Further, various doses of ACTH analogs have been used to test adrenal function in premature infants, without consensus on appropriate dose or adequate response. 11, 29, 30 In one study, 1.0 mcg kg À1 cosyntropin was preferable to lower doses of 0.1 mcg kg À1 in differentiating between groups of infants with clinical conditions that could influence the response. 31 Karlsson et al. 32 demonstrated that the cortisol value reaches its peak after ACTH administration at 40 min in the low-dose ACTH tests (1 mg 1.73 m
À2
) and at 60 min with higher dose (250 mg 1.73 mÀ 2 ). More recent studies have performed an ACTH test using only one post stimulation cortisol sampling. 31 As preterm infants do not exhibit diurnal rhythm, sampling can occur anytime. 24, 33 Thus, based on previous studies, we decided to use 1.0 mcg kg À1 cosyntropin with cortisol levels before and 40 min after cosyntropin administration. In order to take into account the wide variability of cortisol levels with and without a stimulation test in healthy and sick neonates, we used the percentage change in cortisol levels from baseline as the result of the study for the ROC curve analysis. The area under the ROC curve for the power of the percentage change in cortisol was 87%. The best combination of sensitivity and specificity of the test was by using an increase in cortisol of <12% from baseline after the ACTH administration. In comparison, using only the post ACTH test cortisol level was less accurate with area under the ROC curve of 74%.
We used significant hypotension as a possible marker for hypoadrenalism, as it can be a relatively early complication of TAI. 5, 23 Hypotension, which occurs in 20 to 40% in very low birth weight infants, 12, 34 is usually defined in the 1st day as mean blood pressure (in mm Hg), which is less than GA in completed weeks, 35, 36 and is associated with brain damage in affected preterm infants. 12 We conducted the test early in the 1st few hours of life as hypotension usually presents during this time and we used hypotension that prompted treatment as our predictors, hence the test may be used as a tool for treatment decision making.
In recent years, neonatologists have developed skills to perform limited bedside functional echocardiography to enhance the care of critically ill babies. 37 We conducted functional echocardiography in 9 out of 12 hypotensive infants before the initiation of inotrope support. The team was blinded to the echocardiography results; they were used to support the diagnosis of hypotension in the infants in the study. In all these tested infants, the left ventricular outflow was <120 ml kg À1 min À1 . This level of function is considered to be a low output state. [38] [39] [40] These results reinforce our diagnosis of true clinically significant hypotension in those patients. The left ventricular outflow in the rest of the infants was significantly higher at 8 h of age.
The sensitivity of the test in our study using an increase in cortisol <12% from baseline after the ACTH administration ('low response to ACTH') was 75%. This finding is not surprising given that different etiologies other than TAI can cause similar clinical conditions contributing to hypotension in the critically ill premature infant (e.g., hypovolemia, myocardial compromise, failure of vasoregulation, hyaline membrane disease, infection or a combination of factors). 13 The high specificity level of 93% indicates that using an increase in cortisol <12% from baseline after the ACTH administration has potential as a marker for identifying hypoadrenalism in these infants.
Two potential limitations of the study are small sample size and the other factors that could have caused the hypotension in our patients. However, none of the hypotensive infants had documented sepsis or asphyxia. Without a gold standard test or sign for TAI, early refractory hypotension without other obvious causes, taken together with the lack of response to ACTH administration, may provide evidence for clinically significant TAI. The high percentage of prenatal steroid treatment made it impossible to assess the effect of its use on the study results.
Conclusion
In this pilot study, administering early ACTH tests using increased cortisol levels of <12% from baseline as a cutoff has high specificity for detecting hypotension, and may be used as a marker for hypoadrenalism in this high risk population. Future studies may use this tool for targeting treatment with steroids for hypotension or as prophylaxis against the development of BPD.
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